Aldevron and Integrated DNA Technologies, Inc. (IDT), a supplier of custom nucleic acid and genome editing products, have announced a license agreement whereby Aldevron will manufacture and distribute a S. pyogenes Cas9 variant—known as SpyFi^TM Cas9 Nuclease—which is patented by IDT. The product will be manufactured for research, clinical, and commercial use.